Literature DB >> 17567308

Toxic epidermal necrolysis: 15 years' experience in a Dutch burns centre.

B Gerdts1, A F P M Vloemans, R W Kreis.   

Abstract

BACKGROUND: Toxic epidermal necrolysis (TEN) is a severe and potentially fatal drug reaction characterized by an extensive skin rash with blisters and exfoliation, frequently accompanied by mucositis. The wounds caused by TEN are similar to second-degree burns and severe cases may involve large areas of skin loss.
OBJECTIVES: Analysis of our results in patients with TEN and evaluation of the variety of therapeutic interventions that has been studied and suggested in TEN. PATIENTS/
METHODS: Retrospective analysis of 19 consecutive patients with TEN treated in our burns centre between 1989 and 2004.
RESULTS: Immediate withdrawal of any potentially fatal drug, maximum supportive care, and a restricted and tailored antibiotic, medical and surgical treatment regimen confined mortality to 21%, whereas prognosis scores like APACHE II and SCORTEN predicted mortality of 22 and 30%, respectively. A positive contribution of selective digestive decontamination is suggested but has yet to be established.
CONCLUSIONS: Because of a potentially fatal outcome, fast referral of a patient suspected of TEN to a specialized centre (mostly a burns unit or specialized dermatology centre) for expert wound management and tailored comprehensive care is strongly advised and contributes to survival.

Entities:  

Mesh:

Year:  2007        PMID: 17567308     DOI: 10.1111/j.1468-3083.2006.02082.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality.

Authors:  Jean-Claude Roujeau; Sylvie Bastuji-Garin
Journal:  Ther Adv Drug Saf       Date:  2011-06

Review 2.  Epidemiology and risk factors for drug allergy.

Authors:  Bernard Y-H Thong; Teck-Choon Tan
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

3.  Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.

Authors:  Ian Chong; Alice Chao
Journal:  Perm J       Date:  2017

Review 4.  Expectations, validity, and reality in pharmacogenetics.

Authors:  Nita A Limdi; David L Veenstra
Journal:  J Clin Epidemiol       Date:  2009-12-07       Impact factor: 6.437

5.  Clinical Features and Treatment Outcomes among Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 20-Year Study in a Tertiary Referral Hospital.

Authors:  Susheera Chatproedprai; Vanvara Wutticharoenwong; Therdpong Tempark; Siriwan Wananukul
Journal:  Dermatol Res Pract       Date:  2018-05-07

6.  Toxic epidermal necrolysis and concurrent granulomatosis with polyangiitis (Wegener's granulomatosis). Management of a rare case and review of the literature.

Authors:  Stratos S Sofos; J Ewing; L C Hughes; M I James
Journal:  Scars Burn Heal       Date:  2016-04-22

7.  Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!

Authors:  Rajesh Kumar; Anupam Das; Sudip Das
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.